Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma

Liver

Volumn 17, Issue 4, 1997, Pages 177-182

  Kira, Shinsuke ^a,c   Nakanishi, Toshio ^a   Suemori, Shoichi ^b   Kitamoto, Mikiya ^a   Watanabe, Yasuyuki ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY   (Japan)

^c Hiroshima Saiseikai Hospital   (Japan)

Author keywords

Epidermal growth factor receptor (EGFR); Hepatocellular carcinoma (HCC); Immunohistochemistry; Transforming growth factor alpha (TGF alpha)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE;

EID: 0030825110     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb00803.x     Document Type: Article

References (33)

1. SALOMON D S, KIM N, SAEKI T, et al. Transforming growth factor α. An oncodevelopmental growth factor. Cancer Cells 1990: 2: 389-397.
2. DERYNCK R. Transforming growth factor-α. Cell 1988: 54: 593-595.
3. KORK M, CHANDRASEKAR B, YAMANAKA Y, et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992: 90: 1352-1360.
4. THOMAS D M, NASHIM M M, GULLICK W J, et al. Immunoreactivity of transforming growth factor-α in the normal adult gastrointestinal tract. Gut 1992: 23: 628-631.
5. TSAO M S, ZHANG X Y. The effects of continuous exposure to epidermal growth factor on the spontaneous transformation of cultured rat liver epithelial cells. Am J Pathol 1992: 140: 85-94.
6. MUTOO Y, SHIMIZU N, HATTORI N, et al. Immunohistochemical analysis of EGF receptor and myc product in human hepatoma cells. Acta Hepatol Jpn 1989: 30: 261-262.
7. YEH Y C, TSAI J F, CHUANG L Y, et al. Elevation of transforming growth factor-α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 1987: 47: 896-901.
8. COFFEY R J, GOUSTIN A S, SODERQUIST A M, et al. Transforming growth factor-α and β expression in human colon cancer lines: implications and autocrine model. Cancer Res 1987: 47: 4590-4599.
9. TANAKA H. Immunohistochemical studies on epidermal growth factor receptor in hepatocellular carcinoma. Nippon Shokakibyo Gakkai Zasshi 1991: 88: 138-144.
10. TANAKA S, IMANISHI K, YOSHIHARA M, et al. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. Am J Pathol 1991: 139: 123-129.
11. MIETTINEN P J Transforming growth factor-alpha and epidermal growth factor expression in human fetal gastrointestinal tract. Pediatr Res 1993: 33: 481-486.
12. PARHAM D M, JANKOWSKI J. Transforming growth factor-α in epithelial proliferative diseases of the breast. J Clin Pathol 1992: 45: 513-516.
13. YASUI W, JI Z Q, KUNIYASU H, et al. Expression of transforming growth factor alpha in human tissues Virchows Arch A Pathol Anat Histopathol 1992: 421: 513-519.
14. SUEMORI S, CIACCI C, PODOLSKY D K. Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 1991: 87: 2216-2221.
15. BARTON C M, HALL P A, HUGHES C M, et al. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991. 163. 111-116.
16. TATEISHI M, ISHIDA T, MITSUDOMI T, et al. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res 1990: 50: 7077-7080.
17. KATOH M, INAGAKI H, KUROSAWA K, et al. Detection of transforming growth factor alpha in human urine and plasma. Biochem Biophys Res Commun 1991: 167: 1065-1072.
18. JHAPPEN C, STAHLE C, HARKINS R, et al. TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990: 61: 1137-1146.
19. SANDGREN E P, LUETTEKE N C, QIU T H, et al. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell J Biol 1993: 13: 320-330.
20. DERYNCK R, GOEDDEL D V, ULLRICH A, et al. Synthesis of messenger RNAs for transforming growth factor-α and β and the epidermal growth factor receptor by human tumor. Cancer Res 1987: 47: 707-712.
21. LEE D C, ROCHFORD R, TODARO G J, et al. Developmental expression of rat transforming growth factor-α mRNA. Mol Cell Biol 1985: 5: 3644-3646.
22. MEAD J E, FAUSTO N. Transforming growth factor may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989: 86: 1558-1562
23. TOMIYA T, FUJIWARA K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 1993: 18: 304-308.
24. DE GROOTE J, DESMET V J, GEDIGK P, et al. A classification of chronic hepatitis. Lancet 1968: 2: 626-628.
25. BIANCHI L, DE GROOTE J, DESMET V J, et al. Acute and chronic hepatitis revisited: review by an international group. Lancet 1977: 2: 914-919.
26. THE LIVER CANCER STUDY GROUP OF JAPAN. The general rules for clinical and pathological study of primary liver cancer (in Japanese). Tokyo: Kanehara, 1992.
27. HERMANEK P, SOBIN L H. TNM classification of malignant tumors. 4th edn. Berlin: Springer-Verlag, 1987: 53-55.
28. EDMONDSON H A, STEINER P E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954: 7: 462-503.
29. HSIA C C, AXIOTIS C A, DI BISCEGLIE A M, et al. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 1992: 70: 1049-1056.
30. COLLIER J D, GUO K, GULLICK W J, et al. Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver 1993: 13: 151-155.
31. MENDELSON J. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Monogr Natl Cancer Inst 1992: 13:125-131.
32. STROMBLAD S, ANDERSON G. The coupling between transforming growth factor receptor-alpha and the epidermal growth factor receptor during rat liver regeneration. Exp Cell Res 1993: 204: 321-328.
33. JANKOWSKI J, MACMENEMIN R, YU C, et al. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut 1992: 33: 587-591.